Table 1: Colorectal Cancer – Pipeline Products by Stage of Development 19
Table 2: Colorectal Cancer – Pipeline Products by Territory 20
Table 3: Colorectal Cancer – Pipeline Products by Regulatory Path 21
Table 4: Colorectal Cancer – Pipeline Products by Estimated Approval Date 22
Table 5: Colorectal Cancer – Ongoing Clinical Trials 23
Table 6: Colorectal Cancer Companies – Pipeline Products by Stage of Development 24
Table 7: Colorectal Cancer – Pipeline Products by Stage of Development 29
Table 8: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
Table 9: Diagnostic Assay – Colorectal Cancer – Product Status 33
Table 10: Diagnostic Assay – Colorectal Cancer – Product Description 33
Table 11: Almac Diagnostic Services Ltd Pipeline Products & Ongoing Clinical Trials Overview 34
Table 12: DNA Damage Response Deficiency Assay – Colorectal Cancer – Product Status 34
Table 13: DNA Damage Response Deficiency Assay – Colorectal Cancer – Product Description 34
Table 14: Ambergen Inc Pipeline Products & Ongoing Clinical Trials Overview 35
Table 15: Veracode – Colorectal Cancer – Product Status 35
Table 16: Veracode – Colorectal Cancer – Product Description 35
Table 17: Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview 36
Table 18: Cchek – Colon Cancer Confirmatory Test – Product Status 36
Table 19: Cchek – Colon Cancer Confirmatory Test – Product Description 36
Table 20: Cchek – Colon Cancer Recurrence Test – Product Status 37
Table 21: Cchek – Colon Cancer Recurrence Test – Product Description 37
Table 22: Cchek – Colon Cancer Screening Test – Product Status 37
Table 23: Cchek – Colon Cancer Screening Test – Product Description 38
Table 24: Cchek – Colon Cancer Treatment Monitoring Test – Product Status 38
Table 25: Cchek – Colon Cancer Treatment Monitoring Test – Product Description 38
Table 26: Anixa Diagnostics Corporation – Ongoing Clinical Trials Overview 39
Table 27: Cchek – Colon Cancer Screening Test – The Coupling of MDSCs with a Computational Analytic Method to Detect Solid Tumors 40
Table 28: Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 29: SimpliPro Colon-A – Product Status 41
Table 30: SimpliPro Colon-A – Product Description 41
Table 31: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 42
Table 32: Biomarker Test – Colorectal Cancer – Product Status 42
Table 33: Biomarker Test – Colorectal Cancer – Product Description 42
Table 34: Arrayit Corporation Pipeline Products & Ongoing Clinical Trials Overview 43
Table 35: Finger Stick Test – Colon Cancer – Product Status 43
Table 36: Finger Stick Test – Colon Cancer – Product Description 43
Table 37: ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview 44
Table 38: ArtemixRx Prognostic Test – Colon Cancer – Product Status 44
Table 39: ArtemixRx Prognostic Test – Colon Cancer – Product Description 44
Table 40: Avant Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 45
Table 41: TheraLink Assay – Colorectal Cancer – Product Status 45
Table 42: TheraLink Assay – Colorectal Cancer – Product Description 45
Table 43: Bio Mark Ltd Pipeline Products & Ongoing Clinical Trials Overview 46
Table 44: Diagnostic Test – Colorectal Adenoma – Product Status 46
Table 45: Diagnostic Test – Colorectal Adenoma – Product Description 46
Table 46: Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview 47
Table 47: Idylla MSI CDx – Product Status 47
Table 48: Idylla MSI CDx – Product Description 47
Table 49: Idylla MSI Test – Product Status 48
Table 50: Idylla MSI Test – Product Description 48
Table 51: Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview 49
Table 52: VeriStrat – Colorectal Cancer – Product Status 49
Table 53: VeriStrat – Colorectal Cancer – Product Description 49
Table 54: BioMarCare Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 50
Table 55: mCRC-Strat – Product Status 50
Table 56: mCRC-Strat – Product Description 50
Table 57: BioMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 51
Table 58: Metabolomics-based Diagnostic Assay – Colorectal Cancer – Product Status 51
Table 59: Metabolomics-based Diagnostic Assay – Colorectal Cancer – Product Description 51
Table 60: BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview 52
Table 61: Ex Vivo Biomarker Test – Colon Cancer – Product Status 52
Table 62: Ex Vivo Biomarker Test – Colon Cancer – Product Description 52
Table 63: Biomoda Inc Pipeline Products & Ongoing Clinical Trials Overview 53
Table 64: CyPath Diagnostic Assay – Colorectal Cancer – Product Status 53
Table 65: CyPath Diagnostic Assay – Colorectal Cancer – Product Description 53
Table 66: Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview 54
Table 67: MBDAA Colorectal Cancer Test – Product Status 54
Table 68: MBDAA Colorectal Cancer Test – Product Description 54
Table 69: BioSystems International Pipeline Products & Ongoing Clinical Trials Overview 55
Table 70: Diagnostic Test – Colon Cancer – Product Status 55
Table 71: Diagnostic Test – Colon Cancer – Product Description 55
Table 72: Biotron Ltd Pipeline Products & Ongoing Clinical Trials Overview 56
Table 73: C-Test – Colorectal Cancer – Product Status 56
Table 74: C-Test – Colorectal Cancer – Product Description 56
Table 75: Calviri Inc Pipeline Products & Ongoing Clinical Trials Overview 57
Table 76: Blood Test – Microsatellite Instability Status – Product Status 57
Table 77: Blood Test – Microsatellite Instability Status – Product Description 57
Table 78: Castle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 58
Table 79: DecisionDx – Rectal Cancer – Product Status 58
Table 80: DecisionDx – Rectal Cancer – Product Description 58
Table 81: Catholic University of Leuven Pipeline Products & Ongoing Clinical Trials Overview 59
Table 82: Diagnostic Test – Colorectal Cancer – Product Status 59
Table 83: Diagnostic Test – Colorectal Cancer – Product Description 59
Table 84: Celcuity Inc Pipeline Products & Ongoing Clinical Trials Overview 60
Table 85: CELsignia Test – Colon Cancer – Product Status 60
Table 86: CELsignia Test – Colon Cancer – Product Description 60
Table 87: CellMax Life Inc Pipeline Products & Ongoing Clinical Trials Overview 61
Table 88: CellMax Monitor – Colorectal Cancer – Product Status 61
Table 89: CellMax Monitor – Colorectal Cancer – Product Description 61
Table 90: Cellmid Ltd Pipeline Products & Ongoing Clinical Trials Overview 62
Table 91: MK-ELISA Assay – Colorectal Cancer – Product Status 62
Table 92: MK-ELISA Assay – Colorectal Cancer – Product Description 62
Table 93: MK-ELISA Assay – Metastatic Colorectal Cancer – Product Status 63
Table 94: MK-ELISA Assay – Metastatic Colorectal Cancer – Product Description 63
Table 95: Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 64
Table 96: Nanotrap Colon Cancer Biomarker Test – Product Status 64
Table 97: Nanotrap Colon Cancer Biomarker Test – Product Description 64
Table 98: Cernostics Inc Pipeline Products & Ongoing Clinical Trials Overview 65
Table 99: TissueCypher Colon Cancer Test – Product Status 65
Table 100: TissueCypher Colon Cancer Test – Product Description 65
Table 101: ChemImage Corp Pipeline Products & Ongoing Clinical Trials Overview 66
Table 102: Raman Assay – Colorectal Cancer – Product Status 66
Table 103: Raman Assay – Colorectal Cancer – Product Description 66
Table 104: China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 67
Table 105: Diagnostic Kit – Rectum Cancer – Product Status 67
Table 106: Diagnostic Kit – Rectum Cancer – Product Description 67
Table 107: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 68
Table 108: IGFBP-3 Diagnostic Test – Product Status 68
Table 109: IGFBP-3 Diagnostic Test – Product Description 68
Table 110: CS-Keys, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 69
Table 111: caPCNA Test – Colorectal Cancer – Product Status 69
Table 112: caPCNA Test – Colorectal Cancer – Product Description 69
Table 113: Di.V.A.L Toscana srl Pipeline Products & Ongoing Clinical Trials Overview 70
Table 114: NanoMabKv – Colorectal Cancer – Product Status 70
Table 115: NanoMabKv – Colorectal Cancer – Product Description 70
Table 116: DiagnoCure Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 71
Table 117: Colorectal/GCC Monitoring Test – Product Status 71
Table 118: Colorectal/GCC Monitoring Test – Product Description 71
Table 119: Colorectal/Shc Prognostic Test – Product Status 72
Table 120: Colorectal/Shc Prognostic Test – Product Description 72
Table 121: Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 73
Table 122: TRAIL-R2 Assay – Product Status 73
Table 123: TRAIL-R2 Assay – Product Description 73
Table 124: DNAlytics SA Pipeline Products & Ongoing Clinical Trials Overview 74
Table 125: ColonoKit – Product Status 74
Table 126: ColonoKit – Product Description 74
Table 127: Duke University Pipeline Products & Ongoing Clinical Trials Overview 75
Table 128: Biomarker Test – Colon Cancer – Product Status 75
Table 129: Biomarker Test – Colon Cancer – Product Description 75
Table 130: EDP Biotech Corporation Pipeline Products & Ongoing Clinical Trials Overview 76
Table 131: ColoPlex – Product Status 76
Table 132: ColoPlex – Product Description 76
Table 133: EntreChem SL Pipeline Products & Ongoing Clinical Trials Overview 77
Table 134: Bacterial Biomarker Test – Colon Cancer – Product Status 77
Table 135: Bacterial Biomarker Test – Colon Cancer – Product Description 77
Table 136: Epigenomics AG Pipeline Products & Ongoing Clinical Trials Overview 78
Table 137: Epi proColon 1.0 – Product Status 78
Table 138: Epi proColon 1.0 – Product Description 78
Table 139: Eurobio Scientific SA Pipeline Products & Ongoing Clinical Trials Overview 79
Table 140: EHT Dx 12 – Product Status 79
Table 141: EHT Dx 12 – Product Description 79
Table 142: Eventus Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 80
Table 143: Octava Test – Colon Cancer – Product Status 80
Table 144: Octava Test – Colon Cancer – Product Description 80
Table 145: Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview 81
Table 146: Cologuard 2.0 – Product Status 81
Table 147: Cologuard 2.0 – Product Description 81
Table 148: Exiqon AS Pipeline Products & Ongoing Clinical Trials Overview 82
Table 149: Colon Cancer Test – Stage III And IV Patient – Product Status 82
Table 150: Colon Cancer Test – Stage III And IV Patient – Product Description 82
Table 151: Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview 83
Table 152: ExoTEST Colorectal – Product Status 83
Table 153: ExoTEST Colorectal – Product Description 83
Table 154: Fina Biotech SL Pipeline Products & Ongoing Clinical Trials Overview 84
Table 155: Dx Bioenergetic Signature – Colon Cancer – Product Status 84
Table 156: Dx Bioenergetic Signature – Colon Cancer – Product Description 84
Table 157: Fox Chase Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 85
Table 158: Diagnostic Test – Colorectal Cancer – Product Status 85
Table 159: Diagnostic Test – Colorectal Cancer – Product Description 85
Table 160: Prognostic Marker – Colorectal Cancer – Product Status 86
Table 161: Prognostic Marker – Colorectal Cancer – Product Description 86
Table 162: GenExosome Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 87
Table 163: EXOSOME Biomarker Assay – Colorectal Cancer – Product Status 87
Table 164: EXOSOME Biomarker Assay – Colorectal Cancer – Product Description 87
Table 165: GenomicTree Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 88
Table 166: EarlyTect Colon Cancer – Product Status 88
Table 167: EarlyTect Colon Cancer – Product Description 88
Table 168: EarlyTect Colorectal Cancer – Recurrence – Product Status 89
Table 169: EarlyTect Colorectal Cancer – Recurrence – Product Description 89
Table 170: GenomicTree Co Ltd – Ongoing Clinical Trials Overview 90
Table 171: EarlyTect Colon Cancer – Colorectal Cancer Screening Using Stool DNA-based SDC2 Methylation Test: A Pilot Study 91
Table 172: German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 92
Table 173: Autoantibody Panel – Colorectal Cancer – Product Status 92
Table 174: Autoantibody Panel – Colorectal Cancer – Product Description 92
Table 175: Biomarker Panel – Colorectal Cancer – Product Status 93
Table 176: Biomarker Panel – Colorectal Cancer – Product Description 93
Table 177: Ghent University Pipeline Products & Ongoing Clinical Trials Overview 94
Table 178: Biomarker Test – Colorectal Cancer – Product Status 94
Table 179: Biomarker Test – Colorectal Cancer – Product Description 94
Table 180: GlycoZym USA Inc Pipeline Products & Ongoing Clinical Trials Overview 95
Table 181: Diagnostic Assay – Colon Cancer – Product Status 95
Table 182: Diagnostic Assay – Colon Cancer – Product Description 95
Table 183: Health Discovery Corp Pipeline Products & Ongoing Clinical Trials Overview 96
Table 184: Diagnostic Test – Colon Cancer – Product Status 96
Table 185: Diagnostic Test – Colon Cancer – Product Description 96
Table 186: Hitachi Chemical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 97
Table 187: Urine Based Diagnostic Test – Colon Cancer – Product Status 97
Table 188: Urine Based Diagnostic Test – Colon Cancer – Product Description 97
Table 189: Human Metabolome Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 98
Table 190: Biomarker Based Assay – Colorectal Cancer – Product Status 98
Table 191: Biomarker Based Assay – Colorectal Cancer – Product Description 98
Table 192: Ikonisys Inc Pipeline Products & Ongoing Clinical Trials Overview 99
Table 193: oncoFISH colorectal – Product Status 99
Table 194: oncoFISH colorectal – Product Description 99
Table 195: Institute of Molecular and Translational Medicine Pipeline Products & Ongoing Clinical Trials Overview 100
Table 196: Diagnostic Biomarker – Colorectal Cancer – Product Status 100
Table 197: Diagnostic Biomarker – Colorectal Cancer – Product Description 100
Table 198: InterGenetics Inc Pipeline Products & Ongoing Clinical Trials Overview 101
Table 199: OncoVue Colon – Product Status 101
Table 200: OncoVue Colon – Product Description 101
Table 201: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 102
Table 202: 5hmC Based Diagnostic Tool – Cancer – Product Status 102
Table 203: 5hmC Based Diagnostic Tool – Cancer – Product Description 102
Table 204: Prognosis Test – Colorectal Cancer – Product Status 103
Table 205: Prognosis Test – Colorectal Cancer – Product Description 103
Table 206: King Abdullah University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 104
Table 207: Diagnostic Test – Colorectal Cancer – Product Status 104
Table 208: Diagnostic Test – Colorectal Cancer – Product Description 104
Table 209: Kyo Diagnostics KK Pipeline Products & Ongoing Clinical Trials Overview 105
Table 210: Diagnostic Test – Colorectal Cancer – Product Status 105
Table 211: Diagnostic Test – Colorectal Cancer – Product Description 105
Table 212: Lab21 Ltd Pipeline Products & Ongoing Clinical Trials Overview 106
Table 213: Onconostica – Product Status 106
Table 214: Onconostica – Product Description 106
Table 215: Laboratorios Alpha San Ignacio Pharma S.L. Pipeline Products & Ongoing Clinical Trials Overview 107
Table 216: OncoSafe – Product Status 107
Table 217: OncoSafe – Product Description 107
Table 218: Leitat Technological Center Pipeline Products & Ongoing Clinical Trials Overview 108
Table 219: ELISA Kit – S100A4 – Colon Cancer – Product Status 108
Table 220: ELISA Kit – S100A4 – Colon Cancer – Product Description 108
Table 221: ELISA Kit – S100P – Colon Cancer – Product Status 109
Table 222: ELISA Kit – S100P – Colon Cancer – Product Description 109
Table 223: MabCure Inc Pipeline Products & Ongoing Clinical Trials Overview 110
Table 224: Diagnostic Test – Colorectal Cancer – Product Status 110
Table 225: Diagnostic Test – Colorectal Cancer – Product Description 110
Table 226: Master Diagnostica Sociedad Limitada Pipeline Products & Ongoing Clinical Trials Overview 111
Table 227: KRAS / NRAS / BRAF Mutation Flow Chip Test – Colon Cancer – Product Status 111
Table 228: KRAS / NRAS / BRAF Mutation Flow Chip Test – Colon Cancer – Product Description 111
Table 229: Matrix-Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 112
Table 230: Companion Diagnostic Test – Colon Cancer – Product Status 112
Table 231: Companion Diagnostic Test – Colon Cancer – Product Description 112
Table 232: VeraMarker CCM Test – Product Status 113
Table 233: VeraMarker CCM Test – Product Description 113
Table 234: VeraMarker CCS Test – Product Status 113
Table 235: VeraMarker CCS Test – Product Description 114
Table 236: Max Delbruck Center for Molecular Medicine Pipeline Products & Ongoing Clinical Trials Overview 115
Table 237: Companion Diagnostic Assay – Colorectal Cancer – Product Status 115
Table 238: Companion Diagnostic Assay – Colorectal Cancer – Product Description 115
Table 239: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 116
Table 240: Blood Test – Colon Cancer – Product Status 116
Table 241: Blood Test – Colon Cancer – Product Description 116
Table 242: MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 117
Table 243: Mitomic Colorectal Test – Product Status 117
Table 244: Mitomic Colorectal Test – Product Description 117
Table 245: MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview 118
Table 246: InformMDx – Colon Cancer – Product Status 118
Table 247: InformMDx – Colon Cancer – Product Description 118
Table 248: PredictMDx – Colon Cancer – Product Status 119
Table 249: PredictMDx – Colon Cancer – Product Description 119
Table 250: Merrimack Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 120
Table 251: MM-151 Companion Diagnostic Assay – Colorectal Cancer – Product Status 120
Table 252: MM-151 Companion Diagnostic Assay – Colorectal Cancer – Product Description 120
Table 253: Metabolon Inc Pipeline Products & Ongoing Clinical Trials Overview 121
Table 254: Diagnostic Test – Colorectal Cancer – Product Status 121
Table 255: Diagnostic Test – Colorectal Cancer – Product Description 121
Table 256: MetaStat Inc Pipeline Products & Ongoing Clinical Trials Overview 122
Table 257: MenaCalc Colorectal – Product Status 122
Table 258: MenaCalc Colorectal – Product Description 122
Table 259: Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview 123
Table 260: Immunoassay – Colon Cancer – Product Status 123
Table 261: Immunoassay – Colon Cancer – Product Description 123
Table 262: Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 124
Table 263: Diagnostic Test – Colon Cancer – Product Status 124
Table 264: Diagnostic Test – Colon Cancer – Product Description 124
Table 265: Nanocytomics LLC Pipeline Products & Ongoing Clinical Trials Overview 125
Table 266: Minimally Intrusive Fecal Test – Colorectal Cancer – Product Status 125
Table 267: Minimally Intrusive Fecal Test – Colorectal Cancer – Product Description 125
Table 268: Norda ASA Pipeline Products & Ongoing Clinical Trials Overview 126
Table 269: Genefec III – Product Status 126
Table 270: Genefec III – Product Description 126
Table 271: Novel Bio-spectrum Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 127
Table 272: NBT Diagnostic Test – Colon Cancer – Product Status 127
Table 273: NBT Diagnostic Test – Colon Cancer – Product Description 127
Table 274: Nuclea Biotechnologies Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 128
Table 275: Colon Cancer Recurrence Diagnostic Test – Product Status 128
Table 276: Colon Cancer Recurrence Diagnostic Test – Product Description 128
Table 277: Oncimmune (USA) LLC Pipeline Products & Ongoing Clinical Trials Overview 129
Table 278: EarlyCDT – Colon Cancer – Product Status 129
Table 279: EarlyCDT – Colon Cancer – Product Description 129
Table 280: OncoCyte Corp Pipeline Products & Ongoing Clinical Trials Overview 130
Table 281: PanC-Dx – Colon Cancer – Product Status 130
Table 282: PanC-Dx – Colon Cancer – Product Description 130
Table 283: Onconome, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 131
Table 284: ColoMark CCSA-4 Serum Assay – Product Status 131
Table 285: ColoMark CCSA-4 Serum Assay – Product Description 131
Table 286: Origin Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 132
Table 287: CRC Test – Product Status 132
Table 288: CRC Test – Product Description 132
Table 289: Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview 133
Table 290: Orion CRC Risk Test – Product Status 133
Table 291: Orion CRC Risk Test – Product Description 133
Table 292: OTraces Inc Pipeline Products & Ongoing Clinical Trials Overview 134
Table 293: Colon Cancer Sera Dx – Product Status 134
Table 294: Colon Cancer Sera Dx – Product Description 134
Table 295: Oxford Cancer Biomarkers Ltd Pipeline Products & Ongoing Clinical Trials Overview 135
Table 296: ColoNav – Product Status 135
Table 297: ColoNav – Product Description 135
Table 298: Oxford Gene Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 136
Table 299: Diagnostic Assay – Colorectal Cancer – Product Status 136
Table 300: Diagnostic Assay – Colorectal Cancer – Product Description 136
Table 301: PleX Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 137
Table 302: Diagnostic Assay – Colorectal Cancer – Product Status 137
Table 303: Diagnostic Assay – Colorectal Cancer – Product Description 137
Table 304: Precision Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview 138
Table 305: Diagnostic Assay – Colorectal Cancer – Product Status 138
Table 306: Diagnostic Assay – Colorectal Cancer – Product Description 138
Table 307: Prediction Sciences LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 139
Table 308: GeneRx Colorectal Cancer Profile – Product Status 139
Table 309: GeneRx Colorectal Cancer Profile – Product Description 139
Table 310: PreMD Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 140
Table 311: Colopath/ColorectAlert – Product Status 140
Table 312: Colopath/ColorectAlert – Product Description 140
Table 313: Prescient Medicine LLC Pipeline Products & Ongoing Clinical Trials Overview 141
Table 314: LifeKit Prevent Colorectal Neoplasia Test – Product Status 141
Table 315: LifeKit Prevent Colorectal Neoplasia Test – Product Description 141
Table 316: Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 142
Table 317: Diagnostic Assay – Colon Cancer – Product Status 142
Table 318: Diagnostic Assay – Colon Cancer – Product Description 142
Table 319: Protein Alternatives SL Pipeline Products & Ongoing Clinical Trials Overview 143
Table 320: COLODETECT – Product Status 143
Table 321: COLODETECT – Product Description 143
Table 322: Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview 144
Table 323: Blood Based Test – Colorectal Cancer – Product Status 144
Table 324: Blood Based Test – Colorectal Cancer – Product Description 144
Table 325: Quest Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 145
Table 326: Diagnostic Assay – Colorectal Cancer – Product Status 145
Table 327: Diagnostic Assay – Colorectal Cancer – Product Description 145
Table 328: Rabin Medical Center Pipeline Products & Ongoing Clinical Trials Overview 146
Table 329: Diagnostic Test – Colon Cancer – Product Status 146
Table 330: Diagnostic Test – Colon Cancer – Product Description 146
Table 331: Rhythm Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 147
Table 332: ColoSTAT – Product Status 147
Table 333: ColoSTAT – Product Description 147
Table 334: Rhythm Biosciences Ltd – Ongoing Clinical Trials Overview 148
Table 335: ColoSTAT – A Prospective, Cross-sectional, Multi-center Study to Evaluate the Clinical Performance of the Colostat in Vitro Diagnostic for the Detection and Evaluation of Biomarkers Associated with the Occurrence of Colorectal Cancer 149
Table 336: RISE Life Science Corp Pipeline Products & Ongoing Clinical Trials Overview 150
Table 337: Diagnostic Test – Colorectal Cancer – Product Status 150
Table 338: Diagnostic Test – Colorectal Cancer – Product Description 150
Table 339: Rosetta Genomics Ltd Pipeline Products & Ongoing Clinical Trials Overview 151
Table 340: miRscreen Test – Colon Cancer – Product Status 151
Table 341: miRscreen Test – Colon Cancer – Product Description 151
Table 342: Sanguine Diagnostics and Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 152
Table 343: Biomarker Test – Colorectal Cancer – Product Status 152
Table 344: Biomarker Test – Colorectal Cancer – Product Description 152
Table 345: Scienion AG Pipeline Products & Ongoing Clinical Trials Overview 153
Table 346: Diagnostic Test – Colon Cancer – Product Status 153
Table 347: Diagnostic Test – Colon Cancer – Product Description 153
Table 348: Seegene Inc Pipeline Products & Ongoing Clinical Trials Overview 154
Table 349: MDx – Colon Cancer – Product Status 154
Table 350: MDx – Colon Cancer – Product Description 154
Table 351: Shuwen Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 155
Table 352: Colorectal Cancer Theranostic Test – Product Status 155
Table 353: Colorectal Cancer Theranostic Test – Product Description 155
Table 354: Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 156
Table 355: Methylated DNA Colon Cancer Diagnostic Test – Product Status 156
Table 356: Methylated DNA Colon Cancer Diagnostic Test – Product Description 156
Table 357: Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 157
Table 358: Biomarker-Based Diagnostic Kit – Colorectal Cancer – Product Status 157
Table 359: Biomarker-Based Diagnostic Kit – Colorectal Cancer – Product Description 157
Table 360: The Walter and Eliza Hall Institute of Medical Research Pipeline Products & Ongoing Clinical Trials Overview 158
Table 361: Blood-Based Screening Test – Colon Cancer – Product Status 158
Table 362: Blood-Based Screening Test – Colon Cancer – Product Description 158
Table 363: TheraDiag SA Pipeline Products & Ongoing Clinical Trials Overview 159
Table 364: Non-invasive Theranostics Test – Metastatic Recurrence – Product Status 159
Table 365: Non-invasive Theranostics Test – Metastatic Recurrence – Product Description 160
Table 366: Non-invasive Theranostics Test – Radiochemotherapy – Product Status 160
Table 367: Non-invasive Theranostics Test – Radiochemotherapy – Product Description 160
Table 368: Treos Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 161
Table 369: PolyPEPI 1018 CDx – Product Status 161
Table 370: PolyPEPI 1018 CDx – Product Description 161
Table 371: Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 162
Table 372: Biomarker Test – Colorectal Cancer – Product Status 162
Table 373: Biomarker Test – Colorectal Cancer – Product Description 162
Table 374: Universal Diagnostics SL Pipeline Products & Ongoing Clinical Trials Overview 163
Table 375: Blood Based Diagnostic Test – Colorectal Cancer – Product Status 163
Table 376: Blood Based Diagnostic Test – Colorectal Cancer – Product Description 163
Table 377: University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 164
Table 378: Diagnostic Test – Colorectal Cancer – Product Status 164
Table 379: Diagnostic Test – Colorectal Cancer – Product Description 164
Table 380: University of Lyon Pipeline Products & Ongoing Clinical Trials Overview 165
Table 381: Biomarker Prognostic Test – Colon Cancer – Product Status 165
Table 382: Biomarker Prognostic Test – Colon Cancer – Product Description 165
Table 383: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 166
Table 384: Peptide Biomarker Test – Colorectal Cancer – Product Status 166
Table 385: Peptide Biomarker Test – Colorectal Cancer – Product Description 166
Table 386: University of Notre Dame Pipeline Products & Ongoing Clinical Trials Overview 167
Table 387: Biomarker Test – Colon Cancer – Product Status 167
Table 388: Biomarker Test – Colon Cancer – Product Description 167
Table 389: University of Texas MD Anderson Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 168
Table 390: Biomarker Based Assay – Colorectal Neoplasia – Product Status 168
Table 391: Biomarker Based Assay – Colorectal Neoplasia – Product Description 168
Table 392: Biomarker Panel – Colorectal Cancer – Product Status 169
Table 393: Biomarker Panel – Colorectal Cancer – Product Description 169
Table 394: University of Turku Pipeline Products & Ongoing Clinical Trials Overview 170
Table 395: Lectin-Nanoparticle Biomarker – Colorectal Cancer – Product Status 170
Table 396: Lectin-Nanoparticle Biomarker – Colorectal Cancer – Product Description 170
Table 397: University of Washington Pipeline Products & Ongoing Clinical Trials Overview 171
Table 398: Diagnostic Test – Colon Cancer – Product Status 171
Table 399: Diagnostic Test – Colon Cancer – Product Description 171
Table 400: University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 172
Table 401: Diagnostic Kit – Colon Cancer – Product Status 172
Table 402: Diagnostic Kit – Colon Cancer – Product Description 172
Table 403: University of Zurich Pipeline Products & Ongoing Clinical Trials Overview 173
Table 404: Serum Marker Test – Colorectal Carcinoma – Product Status 173
Table 405: Serum Marker Test – Colorectal Carcinoma – Product Description 173
Table 406: US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview 174
Table 407: Blood-Based Biomarker – Colorectal Cancer – Product Status 174
Table 408: Blood-Based Biomarker – Colorectal Cancer – Product Description 174
Table 409: vall d hebron institut de Recerca Pipeline Products & Ongoing Clinical Trials Overview 175
Table 410: Aprataxin Biomarker – Colorectal Cancer – Product Status 175
Table 411: Aprataxin Biomarker – Colorectal Cancer – Product Description 175
Table 412: Companion Diagnostic Assay – Colon Cancer – Product Status 176
Table 413: Companion Diagnostic Assay – Colon Cancer – Product Description 176
Table 414: Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 177
Table 415: Diagnostic Test – High-Risk Stage II Colorectal Cancer – Product Status 177
Table 416: Diagnostic Test – High-Risk Stage II Colorectal Cancer – Product Description 177
Table 417: VICC Blood-Based Diagnostic Test – Colorectal Cancer – Product Status 178
Table 418: VICC Blood-Based Diagnostic Test – Colorectal Cancer – Product Description 178
Table 419: Vastcon Inc Pipeline Products & Ongoing Clinical Trials Overview 179
Table 420: Screening Test – Colorectal Cancer – Product Status 179
Table 421: Screening Test – Colorectal Cancer – Product Description 179
Table 422: Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview 180
Table 423: Viomics Diagnostic Assay – Colon Cancer – Product Status 180
Table 424: Viomics Diagnostic Assay – Colon Cancer – Product Description 180
Table 425: VolitionRX Ltd Pipeline Products & Ongoing Clinical Trials Overview 181
Table 426: Nu.Q CRC Screening Test – Product Status 181
Table 427: Nu.Q CRC Screening Test – Product Description 182
Table 428: Nu.Q CRC Symptomatic Test – Product Status 182
Table 429: Nu.Q CRC Symptomatic Test – Product Description 182
Table 430: Nu.Q CRC Triage Test – Product Status 183
Contd..
